What is the general Beers Criteria recommendation regarding the number of CNS-active drugs in a patient?

Study for the AGS Beers Criteria Test. Prepare with flashcards and multiple choice questions, each with hints and explanations. Get ready for your exam with comprehensive resources!

Multiple Choice

What is the general Beers Criteria recommendation regarding the number of CNS-active drugs in a patient?

Explanation:
The Beers Criteria stress that exposure to central nervous system–active medications in older adults should be kept as low as possible. Each additional CNS-active drug can add to sedation, confusion, delirium, and the risk of falls or cognitive decline, so the general guidance is to minimize the total number of CNS-active drugs a patient takes. If a CNS-active medication is needed, use the lowest effective dose and reassess regularly, preferring non-drug or non-CNS strategies when feasible. The other choices aren’t as aligned with the main point: total avoidance of all CNS-active meds isn’t always appropriate, there’s no fixed number to maintain, and while using drugs only when necessary is important, the question specifically targets reducing the number of CNS-active medications.

The Beers Criteria stress that exposure to central nervous system–active medications in older adults should be kept as low as possible. Each additional CNS-active drug can add to sedation, confusion, delirium, and the risk of falls or cognitive decline, so the general guidance is to minimize the total number of CNS-active drugs a patient takes. If a CNS-active medication is needed, use the lowest effective dose and reassess regularly, preferring non-drug or non-CNS strategies when feasible. The other choices aren’t as aligned with the main point: total avoidance of all CNS-active meds isn’t always appropriate, there’s no fixed number to maintain, and while using drugs only when necessary is important, the question specifically targets reducing the number of CNS-active medications.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy